Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44020351HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44033383HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44017263HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44012250HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44046578HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TCGA Plot Options
Drug Information
GeneGUCY1A2
DrugBank IDDB09241
Drug NameMethylene blue
Target IDBE0003578
UniProt IDP33402
Regulation Typeinhibitor
PubMed IDs21547182; 27047301; 10439772; 19760660
CitationsGinimuge PR, Jyothi SD: Methylene blue: revisited. J Anaesthesiol Clin Pharmacol. 2010 Oct;26(4):517-20.@@Evora PR: Methylene Blue Is a Guanylate Cyclase Inhibitor That Does Not Interfere with Nitric Oxide Synthesis. Tex Heart Inst J. 2016 Feb 1;43(1):103. doi: 10.14503/THIJ-15-5629. eCollection 2016 Feb.@@Masaki E, Kondo I: Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats. Anesth Analg. 1999 Aug;89(2):484-9. doi: 10.1097/00000539-199908000-00045.@@Oz M, Lorke DE, Hasan M, Petroianu GA: Cellular and molecular actions of Methylene Blue in the nervous system. Med Res Rev. 2011 Jan;31(1):93-117. doi: 10.1002/med.20177.
GroupsApproved; Investigational
Direct ClassificationBenzothiazines
SMILES[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1
Pathways
PharmGKB
ChEMBLCHEMBL405110